Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Biovitrum completes its IPO; brings in SEK770mm

Executive Summary

Biovitrum (developing compounds for conditions that include obesity, diabetes, inflammation, and blood diseases) has raised SEK770mm ($105.2mm) with the initial public offering of 7.7mm common shares (including the overallotment) priced at SEK100 each.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies